Visionary biotech leader with 28+ years of global experience driving innovation, growth, and patient impact across oncology, hematology, and cell & gene therapy. Proven CEO, board chair, and company builder with a track record of founding and scaling cutting-edge immuno-oncology platforms, securing strategic funding, building elite scientific teams, and delivering breakthrough therapeutics from concept to clinic and commercialization.